Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QR-333 for Symptomatic Diabetic Peripheral Neuropathy
NCT00568035Phase 2Completed
- Sponsor
- Quigley Pharma Inc.
- Start
- Dec 2006
- Primary completion
- Nov 2008
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 2 trial of QR-333 in diabetic peripheral neuropathy (DPN), sponsored by Quigley Pharma Inc.. Started Dec 2006; status: completed.
02
Drugs
QR-333
03
Conditions
diabetic peripheral neuropathy (DPN)
Beyond the preview
Go deeper on NCT00568035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00568035.